• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

Topical dapsone gel offers dual mode of action in phase III studies

Modality has antibacterial activity against P. acnes and an independent,potent anti-inflammatory effect

Related Videos
Related Content
GPP Therapies: Comparing Efficacy and Safety of Secukinumab and Ustekinumab
October 4th 2024

GPP Therapies: Comparing Efficacy and Safety of Secukinumab and Ustekinumab

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Significant Proportion of Patients With AD Maintain Stable EASI With Tralokinumab Treatment
October 4th 2024

Significant Proportion of Patients With AD Maintain Stable EASI With Tralokinumab Treatment

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Thyroid Disorders and Their Link to Alopecia Areata
October 3rd 2024

Thyroid Disorders and Their Link to Alopecia Areata

Clinical Features and Cytokine Pathways in Prurigo Nodularis vs Atopic Dermatitis
October 3rd 2024

Clinical Features and Cytokine Pathways in Prurigo Nodularis vs Atopic Dermatitis

© 2024 MJH Life Sciences

All rights reserved.